{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:23:19Z","timestamp":1790360599828,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Emergency Medicine Foundation","award":["6531011199"],"award-info":[{"award-number":["6531011199"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Opioid overdoses are at an epidemic in the United States causing the deaths of thousands each year. Project DAWN (Deaths Avoided with Naloxone) is an opioid overdose education and naloxone distribution program in Ohio that distributes naloxone rescue kits at clinics and in the emergency departments of a single hospital system.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a retrospective analytic cohort study comparing heroin overdose survivors who presented to the emergency department and were subsequently discharged. We compared those who received a naloxone rescue kit at discharge with those who did not. Our composite outcome was repeat opioid overdose related emergency department visit(s), hospitalization and death at 0\u20133\u2009months and at 3\u20136\u2009months following emergency department overdose. Heroin overdose encounters were identified by ICD- 9 or 10 codes and data was abstracted from the electronic medical record for emergency department patients who presented for heroin overdose and were discharged over a 31- month period between 2013 and 2016. Patients were excluded for previous naloxone access, incarceration, suicidal ideation, admission to the hospital or death from acute overdose on initial emergency department presentation. Data was analyzed with the Chi- square statistical test.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 291emergency department heroin overdose encounters by ICD-9 or 10 codes and were analyzed. A total of 71% of heroin overdose survivors received a naloxone rescue kit at emergency department discharge. Between the patients who did not receive a naloxone rescue kit at discharge, no overdose deaths occurred and 10.8% reached the composite outcome. Of the patients who received a naloxone rescue kit, 14.4% reached the composite endpoint and 7 opioid overdose deaths occurred in this cohort. No difference in mortality at 3 or 6\u2009months was detected,<jats:italic>p<\/jats:italic>\u2009=\u20090.15 and 0.36 respectively. No difference in the composite outcome was detected at 3 or 6\u2009months either,<jats:italic>p<\/jats:italic>\u2009=\u20090.9 and 0.99 respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Of our emergency department patients receiving a naloxone rescue kit we did not find a benefit in the reduction of repeat emergency department visits hospitalizations, or deaths following a non-fatal heroin overdose.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12913-019-4734-5","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T16:04:04Z","timestamp":1576080244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Take -home naloxone rescue kits following heroin overdose in the emergency department to prevent opioid overdose related repeat emergency department visits, hospitalization and death- a pilot study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5974-7630","authenticated-orcid":false,"given":"Joan","family":"Papp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Vallabhaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon W.","family":"Schrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"issue":"1","key":"4734_CR1","first-page":"10","volume":"61","author":"Centers for Disease C, Prevention","year":"2012","unstructured":"Centers for Disease C, Prevention. CDC grand rounds: prescription drug overdoses - a U.S. epidemic. MMWR Morb Mortal Wkly Rep. 2012;61(1):10\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50\u201351","key":"4734_CR2","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","volume":"64","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50\u201351):1378\u201382.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"4734_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","volume":"67","author":"P Seth","year":"2018","unstructured":"Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants - United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018;67(12):349\u201358.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"4734_CR4","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/ajt.14905","volume":"18","author":"P Seth","year":"2018","unstructured":"Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants - United States, 2015-2016. Am J Transplant. 2018;18(6):1556\u201368.","journal-title":"Am J Transplant"},{"issue":"5152","key":"4734_CR5","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","volume":"67","author":"L Scholl","year":"2018","unstructured":"Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419\u201327.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"34","key":"4734_CR6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.15585\/mmwr.mm6634a3","volume":"66","author":"R Daniulaityte","year":"2017","unstructured":"Daniulaityte R, Juhascik MP, Strayer KE, Sizemore IE, Harshbarger KE, Antonides HM, et al. Overdose deaths related to fentanyl and its analogs - Ohio, January-February 2017. MMWR Morb Mortal Wkly Rep. 2017;66(34):904\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"4734_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","volume":"71","author":"TJ Cicero","year":"2014","unstructured":"Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiat. 2014;71(7):821\u20136.","journal-title":"JAMA Psychiat"},{"issue":"26","key":"4734_CR8","first-page":"719","volume":"64","author":"CMLJ Jones","year":"2015","unstructured":"Jones CMLJ, Gladden RM, Bohm MK. Vital signs: demographic and substance use trends among heroin users - United States, 2002-2013. MMWR Morb Mortal Wkly Rep. 2015;64(26):719\u201325.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4734_CR9","unstructured":"Spencer MR WM, Bastian BA, Trinidad JP, Hedegaard H. Drug overdose deaths involving fentanyl, 2011\u20132016. National Vital Statistics Reports; vol 68 no 3. Hyattsville: National Center for Health Statistics. 2019."},{"key":"4734_CR10","unstructured":"Increases in Fentanyl Drug Confiscations and Fentanyl-Related Overdose Fatalities. Atlanta, Georgia2015 [updated October 26, 2015. Official CDC Health Advisory]. Available from: www.emergency.cdc.gov\/han\/han00384.asp."},{"issue":"33","key":"4734_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","volume":"65","author":"RM Gladden","year":"2016","unstructured":"Gladden RM, Martinez P, Seth P. Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths - 27 states, 2013-2014. MMWR Morb Mortal Wkly Rep. 2016;65(33):837\u201343.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"4734_CR12","first-page":"1","volume":"68","author":"MR Spencer","year":"2019","unstructured":"Spencer MR, Warner M, Bastian BA, Trinidad JP, Hedegaard H. Drug overdose deaths involving fentanyl, 2011-2016. Natl Vital Stat Rep. 2019;68(3):1\u201319.","journal-title":"Natl Vital Stat Rep"},{"issue":"9","key":"4734_CR13","first-page":"1","volume":"67","author":"H Hedegaard","year":"2018","unstructured":"Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs Most frequently involved in drug overdose deaths: United States, 2011-2016. Natl Vital Stat Rep. 2018;67(9):1\u201314.","journal-title":"Natl Vital Stat Rep"},{"issue":"2","key":"4734_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/jurban\/jtg030","volume":"80","author":"M Hickman","year":"2003","unstructured":"Hickman M, Carnwath Z, Madden P, Farrell M, Rooney C, Ashcroft R, et al. Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London. J Urban Health. 2003;80(2):274\u201387.","journal-title":"J Urban Health"},{"issue":"Suppl 2","key":"4734_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/add.12904","volume":"110","author":"J Strang","year":"2015","unstructured":"Strang J. Death matters: understanding heroin\/opiate overdose risk and testing potential to prevent deaths. Addiction. 2015;110(Suppl 2):27\u201335.","journal-title":"Addiction."},{"issue":"1","key":"4734_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/08897077.2017.1356789","volume":"39","author":"AL Bahorik","year":"2018","unstructured":"Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Young-Wolff KC, Campbell CI. Alcohol, marijuana, and opioid use disorders: 5-year patterns and characteristics of emergency department encounters. Subst Abus. 2018;39(1):59\u201368.","journal-title":"Subst Abus"},{"issue":"7","key":"4734_CR17","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1080\/10826084.2019.1568495","volume":"54","author":"WS John","year":"2019","unstructured":"John WS, Wu LT. Sex differences in the prevalence and correlates of emergency department utilization among adults with prescription opioid use disorder. Subst Use Misuse. 2019;54(7):1178\u201390.","journal-title":"Subst Use Misuse"},{"key":"4734_CR18","volume-title":"Ann Emerg Med: One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose","author":"SG Weiner","year":"2019","unstructured":"Weiner SG, Baker O, Bernson D, Schuur JD. Ann Emerg Med: One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose; 2019."},{"key":"4734_CR19","doi-asserted-by":"crossref","unstructured":"Samuels EA, Baird J, Yang ES, Mello MJ. Adoption and Utilization of an Emergency Department Naloxone Distribution and Peer Recovery Coach Consultation Program. Acad Emerg Med. 2019;26(2):160\u201373.","DOI":"10.1111\/acem.13545"},{"issue":"10","key":"4734_CR20","first-page":"38","volume":"97","author":"E Samuels","year":"2014","unstructured":"Samuels E. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths. R I Med J (2013). 2014;97(10):38\u20139.","journal-title":"R I Med J (2013)"},{"issue":"6","key":"4734_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s11606-017-3993-2","volume":"32","author":"G D'Onofrio","year":"2017","unstructured":"D'Onofrio G, Chawarski MC, O'Connor PG, Pantalon MV, Busch SH, Owens PH, et al. Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention. J Gen Intern Med. 2017;32(6):660\u20136.","journal-title":"J Gen Intern Med"},{"issue":"16","key":"4734_CR22","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jama.2015.3474","volume":"313","author":"G D'Onofrio","year":"2015","unstructured":"D'Onofrio G, O'Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, et al. Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636\u201344.","journal-title":"JAMA."},{"issue":"5","key":"4734_CR23","doi-asserted-by":"publisher","first-page":"788","DOI":"10.2105\/AJPH.2008.146647","volume":"99","author":"M Doe-Simkins","year":"2009","unstructured":"Doe-Simkins M, Walley AY, Epstein A, Moyer P. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health. 2009;99(5):788\u201391.","journal-title":"Am J Public Health"},{"issue":"6","key":"4734_CR24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3109\/10826089409047912","volume":"29","author":"N Loimer","year":"1994","unstructured":"Loimer N, Hofmann P, Chaudhry HR. Nasal administration of naloxone is as effective as the intravenous route in opiate addicts. Int J Addict. 1994;29(6):819\u201327.","journal-title":"Int J Addict"},{"issue":"1","key":"4734_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s13346-012-0092-0","volume":"3","author":"DP Wermeling","year":"2013","unstructured":"Wermeling DP. A response to the opioid overdose epidemic: naloxone nasal spray. Drug Deliv Transl Res. 2013;3(1):63\u201374.","journal-title":"Drug Deliv Transl Res"},{"issue":"23","key":"4734_CR26","first-page":"631","volume":"64","author":"E Wheeler","year":"2015","unstructured":"Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(23):631\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"4734_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-158-1-201301010-00003","volume":"158","author":"PO Coffin","year":"2013","unstructured":"Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158(1):1\u20139.","journal-title":"Ann Intern Med"},{"key":"4734_CR28","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","volume":"346","author":"AY Walley","year":"2013","unstructured":"Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.","journal-title":"BMJ."},{"key":"4734_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1471-2458-14-297","volume":"14","author":"M Doe-Simkins","year":"2014","unstructured":"Doe-Simkins M, Quinn E, Xuan Z, Sorensen-Alawad A, Hackman H, Ozonoff A, et al. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health. 2014;14:297.","journal-title":"BMC Public Health"},{"issue":"3","key":"4734_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5811\/westjem.2015.2.24909","volume":"16","author":"K Dwyer","year":"2015","unstructured":"Dwyer K, Walley AY, Langlois BK, Mitchell PM, Nelson KP, Cromwell J, et al. Opioid education and nasal naloxone rescue kits in the emergency department. West J Emerg Med. 2015;16(3):381\u20134.","journal-title":"West J Emerg Med"},{"key":"4734_CR31","volume-title":"Final drug deaths report","author":"T Gilson","year":"2016","unstructured":"Gilson T. Final drug deaths report; 2016."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-019-4734-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-019-4734-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-019-4734-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T21:48:11Z","timestamp":1695505691000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-019-4734-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4734"],"URL":"https:\/\/doi.org\/10.1186\/s12913-019-4734-5","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"20 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the MetroHealth System\u2019s Institutional Review Board (IRB) which provided a waiver of informed consent for this study.Reference number IRB16\u201300077","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"957"}}